Madison Avenue Partners’s Theravance Biopharma TBPH Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$154M	Hold	9,511,150	–	–	6.71%	6
2025 Q4	$178M	Hold	9,511,150	–	–	7.65%	6
2025 Q3	$139M	Hold	9,511,150	–	–	8.29%	7
2025 Q2	$105M	Hold	9,511,150	–	–	7%	6
2025 Q1	$84.9M	Hold	9,511,150	–	–	7.21%	5
2024 Q4	$89.5M	Hold	9,511,150	–	–	9.48%	4
2024 Q3	$76.7M	Buy	9,511,150 +999,800	+12%	+$8.66M	7.11%	6
2024 Q2	$72.2M	Buy	8,511,350 +1,499,124	+21%	+$13.5M	9.12%	4
2024 Q1	$62.9M	Hold	7,012,226	–	–	10.15%	3
2023 Q4	$78.8M	Hold	7,012,226	–	–	11.13%	3
2023 Q3	$60.5M	Hold	7,012,226	–	–	8.59%	4
2023 Q2	$72.6M	Hold	7,012,226	–	–	15.83%	3
2023 Q1	$76.1M	Hold	7,012,226	–	–	16.36%	2
2022 Q4	$78.7M	Hold	7,012,226	–	–	13.94%	2
2022 Q3	$71.1M	Sell	7,012,226 -257,358	-4%	-$2.41M	15.25%	2
2022 Q2	$65.9M	Hold	7,269,584	–	–	13.47%	2
2022 Q1	$69.5M	Buy	7,269,584 +621,559	+9%	+$6.09M	12.98%	2
2021 Q4	$73.5M	Buy	6,648,025 +1,718,602	+35%	+$15M	15.9%	2
2021 Q3	$36.5M	Buy	+4,929,423	New	+$55.1M	8.08%	7